Safety and Efficacy Analysis of FRED® Embolic Device in Aneurysm Treatment

NCT02921698 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2018-05-17

No results posted yet for this study

Summary

A prospective, multicenter, observational evaluation of the safety and efficacy of the FRED® device in the treatment of intracranial aneurysms.

Conditions

  • Intracranial Aneurysms

Interventions

DEVICE

FRED®

Flow Re-Direction Endoluminal Device

Sponsors & Collaborators

  • Microvention-Terumo, Inc.

    lead INDUSTRY

Principal Investigators

  • Laurent Pierot, Prof. · CHU Reims; Reims, France

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2017-02-28
Completion
2017-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02921698 on ClinicalTrials.gov